Concepedia

Helen Barnacle

HB

Statistics

Publications

8

Citations

888

H-Index

8

Active since

1993

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Wellcome Trust

University of Cambridge

GlaxoSmithKline (United States)

University of Pennsylvania

Helen Barnacle is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

1993–2017

8

Publications

8

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 330 citations · Full text

, , +17

A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma

Ronald E. Dahl, Bo Lundbäck, Jean-Luc Malo et al. · CHEST Journal · 1993 · 183 citations

, , +6

An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease

David A. Lomas, David A. Lipson, Bruce E. Miller et al. · The Journal of Clinical Pharmacology · 2011 · 114 citations

, , +17

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

Henrik Watz, Helen Barnacle, Benjamin Hartley et al. · The Lancet Respiratory Medicine · 2013 · 94 citations

, , +7

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Steven Pascoe, David A. Lipson, Nicholas Locantore et al. · European Respiratory Journal · 2016 · 88 citations · Full text

, , +17

1–5 of 8